To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Arthroscopy Fluid Management Disposables Market size was valued at USD 21.09 billion in 2019 and is poised to grow from USD 22.6 billion in 2023 to USD 41.9 billion by 2031, growing at a CAGR of 8.5% in the forecast period (2024-2031).

The Arthroscopy Fluid Management Disposables market is relatively fragmented, with a high level of competition. Companies are working on new product launches and other initiatives to provide better equipment to their customers and expand their company globally. These industry leaders are expanding their client base in a variety of ways, and many organizations are forming strategic and creative partnerships with other start-up businesses in order to increase market share and profitability. 'Arthrex', 'Stryker', 'Smith & Nephew', 'Johnson & Johnson', 'Karl Storz SE & Co. KG', 'Olympus Corporation', 'CONMED Corporation', 'Medtronic plc', 'B. Braun Melsungen AG', 'Zimmer Biomet Holdings, Inc.', 'Becton, Dickinson and Company', 'Teleflex Incorporated', 'Cook Medical Inc.', 'Takeda Pharmaceutical Company Limited', 'Boston Scientific Corporation', 'Baxter International Inc.', 'Cardinal Health, Inc.', 'Fresenius SE & Co. KGaA', 'Abbott Laboratories', 'Merit Medical Systems, Inc.'

Innovative technical developments that improve arthroscopic surgeries will support market expansion going forward. Furthermore, the capacity of fluid management systems to optimise the visualisation process is anticipated to increase demand. The first-ever prospective clinical study findings to assess the efficacy of mending Horizontal Cleavage Tears (HCTs) using Smith & Nephew's NOVOSTITCH Meniscal Repair System were released in July 2019 by Smith & Nephew. Additionally, the increasing use of the all-arthroscopic Latarjet (aL) method to treat recurrent shoulder instability is projected to present market participants with lucrative development potential.

Patients have been turning to web-based technologies and online resources more frequently during the past few years to get information on particular disorders. The rising senior population and government measures to control the cost of various types of orthopedic surgery in the area may help the arthroscopy fluid management disposables market develop. In Europe, there is a tendency toward a greater preference for minimally invasive surgical techniques in nations like Scotland, Germany, and the United Kingdom.

With a maximum revenue of USD 127.7 Mn in 2021, North America led the market and will continue to do so throughout the projected period. The rise is related to improved Medicare reimbursement regulations and the strategic presence of important orthopaedic device businesses in the U.S. The International Trade Administration, using data from the Census Bureau, estimates that there are between 5,300 and 5,600 U.S. enterprises in the medical devices industry, with between 330,000 and 365,000 people employed there.

Feedback From Our Clients

Global Arthroscopy Fluid Management Disposables Market

Product ID: SQSG35A2024

$5,300
BUY NOW